Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study to Investigate the Prevalence of NTRK Gene Fusion Positive in Solid Tumor in Japan

NCT05793281 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05793281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05793281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study to Investigate the Prevalence of NTRK Gene Fusion Positive in Solid Tumor in Japan
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
March 10, 2023
Completion date
September 28, 2023
Enrollment
46,621 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or recurrent solid tumor harboring an ntrk gene fusion